ES450309A1 - Procedimiento para preparar compuestos anti-histaminicos. - Google Patents

Procedimiento para preparar compuestos anti-histaminicos.

Info

Publication number
ES450309A1
ES450309A1 ES450309A ES450309A ES450309A1 ES 450309 A1 ES450309 A1 ES 450309A1 ES 450309 A ES450309 A ES 450309A ES 450309 A ES450309 A ES 450309A ES 450309 A1 ES450309 A1 ES 450309A1
Authority
ES
Spain
Prior art keywords
sulfur
formula
chno2
methylene
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450309A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES450309A1 publication Critical patent/ES450309A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES450309A 1975-07-31 1976-07-30 Procedimiento para preparar compuestos anti-histaminicos. Expired ES450309A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31968/75A GB1565647A (en) 1975-07-31 1975-07-31 Pharmacologically active compounds 4-substituted-imidazole-5-methanols

Publications (1)

Publication Number Publication Date
ES450309A1 true ES450309A1 (es) 1977-12-01

Family

ID=10331071

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450309A Expired ES450309A1 (es) 1975-07-31 1976-07-30 Procedimiento para preparar compuestos anti-histaminicos.

Country Status (28)

Country Link
JP (1) JPS5219663A (de)
AR (1) AR213100A1 (de)
AT (1) AT356668B (de)
AU (1) AU508262B2 (de)
BE (1) BE843840A (de)
CA (1) CA1075702A (de)
CS (1) CS203054B2 (de)
DD (1) DD125205A5 (de)
DE (1) DE2634430A1 (de)
DK (1) DK316376A (de)
ES (1) ES450309A1 (de)
FI (1) FI762191A (de)
FR (1) FR2319341A1 (de)
GB (1) GB1565647A (de)
GR (1) GR61114B (de)
HU (1) HU174068B (de)
IL (1) IL50006A0 (de)
LU (1) LU75495A1 (de)
NL (1) NL7608505A (de)
NO (1) NO762659L (de)
OA (1) OA05405A (de)
PH (1) PH13417A (de)
PT (1) PT65377B (de)
RO (1) RO72312B (de)
SE (1) SE7608478L (de)
SU (1) SU655310A3 (de)
ZA (1) ZA763686B (de)
ZM (1) ZM9676A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4112234A (en) 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0008596A1 (de) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Verfahren zur Herstellung von 4-Hydroxymethyl-imidazolderivaten aus übereinstimmenden 4-Imidazolkarbonsäureestern
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
JPS5914460B2 (ja) * 1978-12-27 1984-04-04 相互薬工株式会社 H↓2受容体「きつ」抗剤シメチジンの製造法
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives

Also Published As

Publication number Publication date
AR213100A1 (es) 1978-12-15
FI762191A (de) 1977-02-01
IL50006A0 (en) 1976-09-30
GB1565647A (en) 1980-04-23
DE2634430A1 (de) 1977-02-10
SE7608478L (sv) 1977-02-01
FR2319341B1 (de) 1979-01-12
PH13417A (en) 1980-03-30
SU655310A3 (ru) 1979-03-30
OA05405A (fr) 1981-02-28
FR2319341A1 (fr) 1977-02-25
DD125205A5 (de) 1977-04-06
JPS5219663A (en) 1977-02-15
CA1075702A (en) 1980-04-15
LU75495A1 (de) 1977-03-03
AT356668B (de) 1980-05-12
BE843840A (fr) 1977-01-06
CS203054B2 (en) 1981-02-27
AU1644776A (en) 1978-02-02
DK316376A (da) 1977-02-01
RO72312B (ro) 1984-03-31
PT65377B (en) 1978-01-19
ZM9676A1 (en) 1977-07-21
ATA552376A (de) 1979-10-15
HU174068B (hu) 1979-10-28
AU508262B2 (en) 1980-03-13
GR61114B (en) 1978-09-13
ZA763686B (en) 1977-05-25
NO762659L (de) 1977-02-01
PT65377A (en) 1976-08-01
RO72312A (ro) 1984-03-15
NL7608505A (nl) 1977-02-02

Similar Documents

Publication Publication Date Title
ES8102107A1 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
ES450309A1 (es) Procedimiento para preparar compuestos anti-histaminicos.
ES467954A1 (es) Procedimiento para preparar piperacino-3-indoles
ES443296A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
ES450318A2 (es) Procedimiento para la produccion de sulfoxidos.
SE7603951L (sv) Forfarande for framstellning av 7-alfa-(4-hydroci-1,5-nafthydrin-3karbonamido)alfa-fenylacetamido-cefalosporinderivat
ES456048A1 (es) Procedimiento de preparacion de derivados de la piridoxina.
ES307983A1 (es) Procedimiento para la preparacion de nuevas amidas de acido ariloxiacetico.
ES465093A1 (es) Procedimiento para la preparacion de un compuesto util como agente antirinovirus.
ES389044A1 (es) Procedimiento para la obtencion de derivados del benzoci- cloheptatiofeno.
ES8207166A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenzofurano.
ES454285A1 (es) Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina.
ES307217A1 (es) Procedimiento para la produccion de compuestos heterociclicos.
ES400623A1 (es) Procedimiento para la preparacion de una composicion farma-ceutica.
ES467734A1 (es) Procedimiento para la obtencion de derivados del 5-nitroimi-dazol.
ES460297A1 (es) Un compuesto.
ES468581A1 (es) Metodo de produccion de compuestos terapeuticos cefalospori-nicos
ES316073A1 (es) Procedimiento para la produccion de derivados piperidinicos de la fenotiacina.
ES458846A1 (es) Un procedimiento para la preparacion de nuevas cefalospori- nas.
ES449570A1 (es) Un procedimiento para la produccion de tetrazolo (a) quina- zol-5-onas.
ES273135A1 (es) Procedimiento de obtenciën de nuevos alcoholes heterociclicos
ES307320A2 (es) Procedimiento para la produccion de compuestos heterociclicos.
ES400478A1 (es) Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.
ES366092A1 (es) Procedimiento para preparar derivados del tiofeno y del fu-rano.
ES431477A1 (es) Procedimiento para preparar derivados de glicerol.